ConquerAb Inc, based in Philadelphia, PA, specializes in innovative rapid diagnostics for detecting antibody responses against biotherapeutic protein drugs. Their proprietary disposable devices enable point-of-care and at-home testing, providing results in under 15 minutes with just a drop of blood.
The company addresses the unmet need for reliable immunogenicity monitoring, facilitating risk assessment and precision medicine for patients undergoing treatment for various diseases. With a focus on standardizing antibody detection, ConquerAb Inc aims to enhance the efficacy and safety of biotherapeutics in a growing multibillion-dollar market.
Generated from the website